Novo Nordisk A/S
XBER:NOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
XBER:NOVA
|
DK |
|
CF Industries Holdings Inc
NYSE:CF
|
US |
|
Bonduelle SA
PAR:BON
|
FR |
|
A
|
Advtech Ltd
JSE:ADH
|
ZA |
|
ING Groep NV
AEX:INGA
|
NL |
|
Nordic Mining ASA
OSE:NOM
|
NO |
|
Alamos Gold Inc
TSX:AGI
|
CA |
|
L
|
Lindbergh SpA
MIL:LDB
|
IT |
|
DP Eurasia NV
LSE:DPEU
|
NL |
|
Morarjee Textiles Ltd
NSE:MORARJEE
|
IN |
|
Inversa Prime Socimi SA
MAD:YIPS
|
ES |
|
Pure Gold Mining Inc
XTSX:PGM
|
CA |
|
Fletcher Building Ltd
F:FLQ
|
NZ |
|
Krispy Kreme Inc
NASDAQ:DNUT
|
US |
|
Focus Universal Inc
NASDAQ:FCUV
|
US |
|
Constellation Technologies Ltd
ASX:CT1
|
AU |
|
Lynas Rare Earths Ltd
ASX:LYC
|
MY |
|
B
|
Boeing Co
SGO:BA
|
US |
|
A
|
Allied Gold Corp
TSX:AAUC
|
CA |
|
P
|
PayPal Holdings Inc
F:2PP
|
US |
|
E
|
El Pollo Loco Holdings Inc
F:EP6
|
US |
Bankruptcy Probability
Novo Nordisk A/S's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novo Nordisk A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
901.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
39.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novo Nordisk A/S's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novo Nordisk A/S has total debt of 118.9B DKK. This includes both short-term (0 DKK) and long-term (118.9B DKK) debt.
You can find a full breakdown on its Balance Sheet.
